GULF INDUSTRIAL TECHNICAL SOLUTION CONTRACTING CO LIMITED

Executive Summary

Orthobiologics Ltd is a very recently established micro-entity with minimal financial data and negligible assets. The lack of trading history and cash flow capacity results in high credit risk at this stage. Credit facilities should be declined until the company demonstrates operational progress and financial strengthening.

ORTHOBIOLOGICS LTD - Analysis Report

Company Number: 15157003

Analysis Date: 2025-07-29 18:18 UTC

1. Credit Opinion: DECLINE
   Orthobiologics Ltd is a newly incorporated micro-entity with minimal financial history and no reported turnover or profit yet. The balance sheet shows nominal current assets of £100 and net assets of £100, indicating the company is at a very early stage with negligible operating activity and no working capital buffer. Given the absence of trading history, revenues, and cash flow generation, the company currently lacks the financial capacity to service any credit facilities. Without further evidence of operational progress, revenue generation, or external financial support, extending credit is high risk.

2. Financial Strength:
   The company’s micro-entity balance sheet reflects extremely limited financial resources. Current assets and net assets stand at only £100, with no fixed assets or liabilities reported. There are no employees, and the company has not yet demonstrated any substantive business activity or asset base. The shareholders’ fund is minimal, fully represented by the initial capital contribution. This fragile financial footing suggests very limited resilience to financial stress or economic downturn.

3. Cash Flow Assessment:
   No cash flow statement or trading results are available. The company’s current assets of £100 suggest very limited liquidity. Without operational revenues or working capital, the company cannot internally generate cash to meet obligations or support growth. The absence of liabilities suggests no current debt obligations, but also no credit history or repayment track record.

4. Monitoring Points:

• Filing of next annual accounts with operational and financial performance data.
• Evidence of revenue generation or contracts secured to support cash flow.
• Changes in capital or external financing arrangements indicating improved financial strength.
• Payment record if any credit facilities or trade credit is extended in future.
• Stability and activity of the sole director and shareholder, Mr. Sarmad Ahmad Khan.